Literature DB >> 35119676

Assessment of Metabolic Regulation by Estrogen Receptors.

Geetanjali Sharma1,2, Eric R Prossnitz3,4,5.   

Abstract

Estrogens, predominantly 17β-estradiol (E2), are a class of steroid hormones critical for diverse functions in the body both during normal physiology and disease. Primary actions of E2 include reproduction and development of secondary sexual characteristics. In addition, E2 action is involved in the nervous, immune, vascular, muscular, skeletal, and endocrine systems, all of which contribute to multiple aspects of metabolism. The actions of E2 have traditionally been attributed to the classical nuclear estrogen receptors (ERα and ERβ) that largely mediate transcriptional/genomic activities. However, over the last decade, the G protein-coupled estrogen receptor (GPER/GPR30) has become recognized as a mediator of rapid as well as transcriptional actions of E2, employing both in vitro and in vivo approaches. Recent evidence strongly supports the role of GPER in metabolic regulation. Murine genetic knockout (KO) models and pharmacological tools (agonists and antagonists) represent important approaches to understand the mechanisms of E2 action in physiology and disease via GPER. Studies in cells and GPER KO mice have revealed functions for GPER in the regulation of body weight and metabolism. This chapter focuses on methods relevant for the evaluation of metabolic parameters in vivo, ex vivo, and in vitro. We have emphasized glucose homeostasis through the determination of glucose and insulin tolerance, pancreatic islet function, and glucose uptake. In addition, we describe methods of adipocyte isolation, differentiation of preadipocytes, and evaluation of mitochondrial function.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adipocyte; Adipose; Estrogen; GPER; Glucose tolerance; Insulin resistance; Insulin sensitivity; Metabolism; Mitochondrial function; Obesity

Mesh:

Substances:

Year:  2022        PMID: 35119676     DOI: 10.1007/978-1-0716-1920-9_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Norfloxacin: a new drug in the treatment of falciparum malaria.

Authors:  P S Sarma
Journal:  Ann Intern Med       Date:  1989-08-15       Impact factor: 25.391

Review 2.  Obesity: definition, comorbidities, causes, and burden.

Authors:  Caroline M Apovian
Journal:  Am J Manag Care       Date:  2016-06       Impact factor: 2.229

Review 3.  Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Authors:  Jean-Philippe Bastard; Mustapha Maachi; Claire Lagathu; Min Ji Kim; Martine Caron; Hubert Vidal; Jacqueline Capeau; Bruno Feve
Journal:  Eur Cytokine Netw       Date:  2006-03       Impact factor: 2.737

4.  Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables.

Authors:  M Garaulet; F Pérez-Llamas; J C Baraza; M D Garcia-Prieto; P S Fardy; F J Tébar; S Zamora
Journal:  J Nutr Health Aging       Date:  2002       Impact factor: 4.075

5.  Sexual dimorphism of age-related changes in whole-body fat distribution in the obese.

Authors:  K Kotani; K Tokunaga; S Fujioka; T Kobatake; Y Keno; S Yoshida; I Shimomura; S Tarui; Y Matsuzawa
Journal:  Int J Obes Relat Metab Disord       Date:  1994-04

Review 6.  Obesity in menopause - our negligence or an unfortunate inevitability?

Authors:  Jarosław Kozakowski; Małgorzata Gietka-Czernel; Dorota Leszczyńska; Agnieszka Majos
Journal:  Prz Menopauzalny       Date:  2017-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.